S 2697 United States Senate · 119th Congress

National Biotechnology Safety Act

S 2697, the National Biotechnology Safety Act, establishes a National Science Foundation program to fund research on the environmental, health, and safety risks of biotechnology products like gene-edited crops or microbes. It authorizes $50 million annually (2026-2030) for research grants to universities, nonprofits, industry, and consortia, focusing on identifying unintended effects, managing risks, and monitoring gene drives. The bill also mandates a two-phase study by the National Academies to compare biotech tools with conventional methods and recommend risk-based regulatory approaches. This research aims to inform federal agencies (like USDA and EPA) and develop clearer safety standards for biotech products, directly affecting researchers, biotech developers, and regulators.
Bill status in committee 1 of 4 stages cleared
Introduction
Sep 2025
Committee Review
Floor Vote
President
Introduced Sep 3, 2025 Last action Sep 3, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Sep 3, 2025
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Sep 3, 2025
Introduced
Introduced in Senate
upper
1 primary · 1 co-sponsor

Sponsors